Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR)
CUSIP: 86366E106
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Ordinary Shares, par value $0.0001 per share
- Shares outstanding
- 213,001,347
- Total 13F shares
- 59,255,636
- Share change
- +15,668,509
- Total reported value
- $2,326,748,242
- Put/Call ratio
- 36%
- Price per share
- $39.27
- Number of holders
- 164
- Value change
- +$609,713,327
- Number of buys
- 121
- Number of sells
- 45
Quarterly Holders Quick Answers
What is CUSIP 86366E106?
CUSIP 86366E106 identifies GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 86366E106:
Top shareholders of GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
2.7%
|
5,827,656
|
$249,773,336 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
1.4%
|
2,948,764
|
$126,384,024 | — | 31 Mar 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.2%
|
2,490,303
|
$106,734,387 | — | 31 Mar 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1.1%
|
2,257,206
|
$96,743,849 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.97%
|
2,076,700
|
$88,994,120 | — | 31 Mar 2024 | |
| TCG Crossover Management, LLC |
13F
|
Company |
0.75%
|
1,598,421
|
$68,508,324 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.73%
|
1,560,950
|
$66,903,000 | — | 31 Mar 2024 | |
| Capital Research Global Investors |
13F
|
Company |
0.72%
|
1,527,483
|
$65,467,921 | — | 31 Mar 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.71%
|
1,510,362
|
$64,734,115 | — | 31 Mar 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.61%
|
1,300,986
|
$55,760,260 | — | 31 Mar 2024 | |
| Capital International Investors |
13F
|
Company |
0.6%
|
1,281,564
|
$54,927,833 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.6%
|
1,275,862
|
$54,683,445 | — | 31 Mar 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
0.57%
|
1,216,303
|
$52,131,000 | — | 31 Mar 2024 | |
| Casdin Capital, LLC |
13F
|
Company |
0.52%
|
1,116,867
|
$47,868,920 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.51%
|
1,086,413
|
$46,563,661 | — | 31 Mar 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.49%
|
1,033,680
|
$44,303,525 | — | 31 Mar 2024 | |
| HSG Holding Ltd |
13F
|
Company |
0.5%
|
1,064,982
|
$38,435,200 | — | 31 Mar 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.41%
|
864,000
|
$37,031,040 | — | 31 Mar 2024 | |
| BVF INC/IL |
13F
|
Company |
0.38%
|
812,988
|
$34,844,666 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.38%
|
810,602
|
$34,742,402 | — | 31 Mar 2024 | |
| Logos Global Management LP |
13F
|
Company |
0.34%
|
720,058
|
$30,861,686 | — | 31 Mar 2024 | |
| Capital World Investors |
13F
|
Company |
0.3%
|
634,160
|
$27,180,098 | — | 31 Mar 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
0.3%
|
629,194
|
$26,967,255 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.25%
|
535,747
|
$22,962,099 | — | 31 Mar 2024 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.24%
|
506,604
|
$21,713,047 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.21%
|
448,671
|
$19,230,039 | — | 31 Mar 2024 | |
| BRAIDWELL LP |
13F
|
Company |
0.2%
|
435,823
|
$18,679,374 | — | 31 Mar 2024 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
413,377
|
$17,717,338 | — | 31 Mar 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.19%
|
412,649
|
$17,686,136 | — | 31 Mar 2024 | |
| Ramy Farid |
3/4/5
|
Director |
—
mixed-class rows
|
3,535,495
mixed-class rows
|
$17,176,500 | — | 07 Feb 2023 | |
| Boxer Capital, LLC |
13F
|
Company |
0.19%
|
400,000
|
$17,144,000 | — | 31 Mar 2024 | |
| MONEY CONCEPTS CAPITAL CORP |
13F
|
Company |
0.18%
|
376,568
|
$16,139,704 | — | 31 Mar 2024 | |
| Bellevue Group AG |
13F
|
Company |
0.17%
|
363,926
|
$15,597,868 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.14%
|
293,633
|
$12,585,126 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.12%
|
261,459
|
$11,206,133 | — | 31 Mar 2024 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.12%
|
255,249
|
$10,939,972 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.1%
|
212,074
|
$9,089,492 | — | 31 Mar 2024 | |
| Altitude Crest Partners Inc. |
13F
|
Company |
0.1%
|
205,166
|
$8,793,415 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.08%
|
179,892
|
$7,710,171 | — | 31 Mar 2024 | |
| Artal Group S.A. |
13F
|
Company |
0.07%
|
151,780
|
$6,505,291 | — | 31 Mar 2024 | |
| First Light Asset Management, LLC |
13F
|
Company |
0.07%
|
149,113
|
$6,390,983 | — | 31 Mar 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.07%
|
143,100
|
$6,133,266 | — | 31 Mar 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.06%
|
135,538
|
$5,809,159 | — | 31 Mar 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.06%
|
135,000
|
$5,786,100 | — | 31 Mar 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.05%
|
100,000
|
$4,286,000 | — | 31 Mar 2024 | |
| Pier Capital, LLC |
13F
|
Company |
0.05%
|
97,557
|
$4,181,293 | — | 31 Mar 2024 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.04%
|
94,714
|
$4,059,442 | — | 31 Mar 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.04%
|
93,794
|
$4,020,011 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.04%
|
90,942
|
$3,897,774 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.04%
|
90,657
|
$3,885,560 | — | 31 Mar 2024 |
Institutional Holders of Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) as of Q2 2024
As of 30 Jun 2024,
Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) was held by
164 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,255,636 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, JANUS HENDERSON GROUP PLC, Capital Research Global Investors, Driehaus Capital Management LLC, BVF INC/IL, FEDERATED HERMES, INC., PRICE T ROWE ASSOCIATES INC /MD/, RA CAPITAL MANAGEMENT, L.P., and Capital International Investors.
This page lists
164
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
119
Q2 2024 holders
164
Holder diff
45
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.